איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
bisoprolol medical valley filmuhúðuð tafla 10 mg
medical valley invest ab - bisoprololum fúmarat - filmuhúðuð tafla - 10 mg
איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
síprox tafla 250 mg
teva b.v.* - ciprofloxacinum hýdróklóríð - tafla - 250 mg
איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoprolol alvogen (metoprolin) tafla 100 mg
alvogen ehf. - metoprololum tartrat - tafla - 100 mg
איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoprolol alvogen (metoprolin) tafla 50 mg
alvogen ehf. - metoprololum tartrat - tafla - 50 mg
איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
cefepima normon stungulyfs-/innrennslisstofn og leysir, lausn 1 g
laboratorios normon s.a. - cefepimum díhýdróklóríð mónóhýdrat - stungulyfs-/innrennslisstofn og leysir, lausn - 1 g
איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
ceftazidim fresenius kabi stungulyfs-/innrennslisstofn, lausn 2000 mg
fresenius kabi ab - ceftazidimum pentahýdrat - stungulyfs-/innrennslisstofn, lausn - 2000 mg
איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
ceftazidim fresenius kabi stungulyfsstofn, lausn 1000 mg
fresenius kabi ab - ceftazidimum pentahýdrat - stungulyfsstofn, lausn - 1000 mg
איסלנד -
איסלנדית -
LYFJASTOFNUN (Icelandic Medicines Agency)
nexplanon (implanon nxt 68 mg vefjalyf) vefjalyf 68 mg
n.v. organon* - etonogestrelum inn - vefjalyf - 68 mg
האיחוד האירופי -
איסלנדית -
EMA (European Medicines Agency)
hemangiol
pierre fabre medicament - própranólól hýdróklóríð - hemangioma - betablokkar - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
האיחוד האירופי -
איסלנדית -
EMA (European Medicines Agency)
sixmo
l. molteni & c. dei fratelli alitti società di esercizio s.p.a. - búprenorfín stutt og long-term - Ópíóíð-tengdir sjúkdómar - Önnur lyf í taugakerfinu - sixmo er ætlað fyrir skipta meðferð fyrir lifur fíkn í vísindalega stöðugt fullorðinn sjúklingum sem þurfa ekki meira en 8 mg/dag á tungu búprenorfín, innan ramma læknis, félagslegar og sálfræðileg meðferð.